nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Podofilox—Teniposide—lung cancer	0.00479	0.239	CbGdCrCtD
Tizanidine—NISCH—Paclitaxel—Docetaxel—lung cancer	0.00443	0.222	CbGdCrCtD
Tizanidine—NISCH—mammary gland—lung cancer	0.00425	0.194	CbGeAlD
Tizanidine—NISCH—Vincristine—Vinorelbine—lung cancer	0.00305	0.152	CbGdCrCtD
Tizanidine—NISCH—Podofilox—Etoposide—lung cancer	0.00285	0.142	CbGdCrCtD
Tizanidine—NISCH—Vinblastine—Vinorelbine—lung cancer	0.00245	0.123	CbGdCrCtD
Tizanidine—NISCH—Vincristine—Vinblastine—lung cancer	0.00244	0.122	CbGdCrCtD
Tizanidine—NISCH—bronchus—lung cancer	0.00233	0.106	CbGeAlD
Tizanidine—NISCH—trachea—lung cancer	0.00209	0.0955	CbGeAlD
Tizanidine—NISCH—bone marrow—lung cancer	0.00166	0.0757	CbGeAlD
Tizanidine—NISCH—lung—lung cancer	0.00151	0.0686	CbGeAlD
Tizanidine—Clonidine—CYP1A1—lung cancer	0.00147	0.653	CrCbGaD
Tizanidine—CYP1A2—respiratory system—lung cancer	0.00112	0.0512	CbGeAlD
Tizanidine—ADRA2C—bronchus—lung cancer	0.00107	0.0486	CbGeAlD
Tizanidine—NISCH—lymph node—lung cancer	0.00103	0.0469	CbGeAlD
Tizanidine—ADRA2C—trachea—lung cancer	0.000957	0.0436	CbGeAlD
Tizanidine—ADRA2C—cardiac atrium—lung cancer	0.000899	0.041	CbGeAlD
Tizanidine—ADRA2A—bronchus—lung cancer	0.00085	0.0388	CbGeAlD
Tizanidine—Clonidine—ABCB1—lung cancer	0.00078	0.347	CrCbGaD
Tizanidine—ADRA2A—trachea—lung cancer	0.000763	0.0348	CbGeAlD
Tizanidine—ADRA2A—cardiac atrium—lung cancer	0.000717	0.0327	CbGeAlD
Tizanidine—ADRA2C—lung—lung cancer	0.000687	0.0313	CbGeAlD
Tizanidine—CYP1A2—lung—lung cancer	0.000597	0.0272	CbGeAlD
Tizanidine—ADRA2A—lung—lung cancer	0.000549	0.025	CbGeAlD
Tizanidine—ADRA2C—lymph node—lung cancer	0.00047	0.0214	CbGeAlD
Tizanidine—ADRA2A—lymph node—lung cancer	0.000375	0.0171	CbGeAlD
Tizanidine—Influenza—Doxorubicin—lung cancer	0.000304	0.000381	CcSEcCtD
Tizanidine—Dysphagia—Doxorubicin—lung cancer	0.000304	0.000381	CcSEcCtD
Tizanidine—Asthma—Doxorubicin—lung cancer	0.000304	0.000381	CcSEcCtD
Tizanidine—Leukopenia—Docetaxel—lung cancer	0.000304	0.000381	CcSEcCtD
Tizanidine—Sweating—Methotrexate—lung cancer	0.0003	0.000376	CcSEcCtD
Tizanidine—Feeling abnormal—Cisplatin—lung cancer	0.0003	0.000376	CcSEcCtD
Tizanidine—Paraesthesia—Etoposide—lung cancer	0.000299	0.000375	CcSEcCtD
Tizanidine—Haematuria—Methotrexate—lung cancer	0.000299	0.000374	CcSEcCtD
Tizanidine—Loss of consciousness—Docetaxel—lung cancer	0.000299	0.000374	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000298	0.000373	CcSEcCtD
Tizanidine—Dyspnoea—Etoposide—lung cancer	0.000297	0.000372	CcSEcCtD
Tizanidine—Somnolence—Etoposide—lung cancer	0.000297	0.000371	CcSEcCtD
Tizanidine—Angina pectoris—Doxorubicin—lung cancer	0.000296	0.000371	CcSEcCtD
Tizanidine—Hepatobiliary disease—Methotrexate—lung cancer	0.000296	0.000371	CcSEcCtD
Tizanidine—Hypersensitivity—Irinotecan—lung cancer	0.000295	0.00037	CcSEcCtD
Tizanidine—Convulsion—Docetaxel—lung cancer	0.000294	0.000369	CcSEcCtD
Tizanidine—Paraesthesia—Paclitaxel—lung cancer	0.000294	0.000368	CcSEcCtD
Tizanidine—Hypertension—Docetaxel—lung cancer	0.000293	0.000367	CcSEcCtD
Tizanidine—Bronchitis—Doxorubicin—lung cancer	0.000293	0.000366	CcSEcCtD
Tizanidine—Agranulocytosis—Methotrexate—lung cancer	0.000292	0.000366	CcSEcCtD
Tizanidine—Dyspnoea—Paclitaxel—lung cancer	0.000292	0.000365	CcSEcCtD
Tizanidine—Somnolence—Paclitaxel—lung cancer	0.000291	0.000364	CcSEcCtD
Tizanidine—Arthralgia—Docetaxel—lung cancer	0.000289	0.000362	CcSEcCtD
Tizanidine—Nausea—Vinorelbine—lung cancer	0.000289	0.000362	CcSEcCtD
Tizanidine—Dyspepsia—Paclitaxel—lung cancer	0.000288	0.000361	CcSEcCtD
Tizanidine—Body temperature increased—Cisplatin—lung cancer	0.000288	0.00036	CcSEcCtD
Tizanidine—Asthenia—Irinotecan—lung cancer	0.000288	0.00036	CcSEcCtD
Tizanidine—Fatigue—Etoposide—lung cancer	0.000288	0.00036	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000287	0.00036	CcSEcCtD
Tizanidine—Constipation—Etoposide—lung cancer	0.000285	0.000357	CcSEcCtD
Tizanidine—Dry mouth—Docetaxel—lung cancer	0.000283	0.000354	CcSEcCtD
Tizanidine—Haemoglobin—Methotrexate—lung cancer	0.000283	0.000354	CcSEcCtD
Tizanidine—Fatigue—Paclitaxel—lung cancer	0.000282	0.000353	CcSEcCtD
Tizanidine—Haemorrhage—Methotrexate—lung cancer	0.000281	0.000352	CcSEcCtD
Tizanidine—Hepatitis—Methotrexate—lung cancer	0.000281	0.000352	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—lung cancer	0.000281	0.000352	CcSEcCtD
Tizanidine—Asthenia—Gemcitabine—lung cancer	0.00028	0.000351	CcSEcCtD
Tizanidine—Constipation—Paclitaxel—lung cancer	0.00028	0.00035	CcSEcCtD
Tizanidine—Confusional state—Docetaxel—lung cancer	0.000279	0.00035	CcSEcCtD
Tizanidine—Pharyngitis—Methotrexate—lung cancer	0.000279	0.00035	CcSEcCtD
Tizanidine—Urinary tract disorder—Methotrexate—lung cancer	0.000278	0.000348	CcSEcCtD
Tizanidine—Anaphylactic shock—Docetaxel—lung cancer	0.000277	0.000347	CcSEcCtD
Tizanidine—Oedema—Docetaxel—lung cancer	0.000277	0.000347	CcSEcCtD
Tizanidine—Pruritus—Gemcitabine—lung cancer	0.000276	0.000346	CcSEcCtD
Tizanidine—Urethral disorder—Methotrexate—lung cancer	0.000276	0.000345	CcSEcCtD
Tizanidine—Infection—Docetaxel—lung cancer	0.000275	0.000345	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—lung cancer	0.000275	0.000345	CcSEcCtD
Tizanidine—Feeling abnormal—Etoposide—lung cancer	0.000275	0.000344	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—lung cancer	0.000274	0.000344	CcSEcCtD
Tizanidine—Diarrhoea—Irinotecan—lung cancer	0.000274	0.000344	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—lung cancer	0.000273	0.000342	CcSEcCtD
Tizanidine—Gastrointestinal pain—Etoposide—lung cancer	0.000273	0.000342	CcSEcCtD
Tizanidine—Shock—Docetaxel—lung cancer	0.000273	0.000342	CcSEcCtD
Tizanidine—Nervous system disorder—Docetaxel—lung cancer	0.000272	0.00034	CcSEcCtD
Tizanidine—Thrombocytopenia—Docetaxel—lung cancer	0.000271	0.00034	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—lung cancer	0.000271	0.00034	CcSEcCtD
Tizanidine—Tachycardia—Docetaxel—lung cancer	0.000271	0.000339	CcSEcCtD
Tizanidine—Feeling abnormal—Paclitaxel—lung cancer	0.000269	0.000338	CcSEcCtD
Tizanidine—Skin disorder—Docetaxel—lung cancer	0.000269	0.000337	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000269	0.000337	CcSEcCtD
Tizanidine—Hypersensitivity—Cisplatin—lung cancer	0.000268	0.000336	CcSEcCtD
Tizanidine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000267	0.000335	CcSEcCtD
Tizanidine—Diarrhoea—Gemcitabine—lung cancer	0.000267	0.000335	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—lung cancer	0.000267	0.000334	CcSEcCtD
Tizanidine—Erythema multiforme—Methotrexate—lung cancer	0.000266	0.000333	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000266	0.000333	CcSEcCtD
Tizanidine—Dizziness—Irinotecan—lung cancer	0.000265	0.000332	CcSEcCtD
Tizanidine—Urticaria—Etoposide—lung cancer	0.000265	0.000332	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—lung cancer	0.000264	0.000331	CcSEcCtD
Tizanidine—Abdominal pain—Etoposide—lung cancer	0.000264	0.00033	CcSEcCtD
Tizanidine—Body temperature increased—Etoposide—lung cancer	0.000264	0.00033	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—lung cancer	0.000264	0.00033	CcSEcCtD
Tizanidine—Tinnitus—Methotrexate—lung cancer	0.000262	0.000328	CcSEcCtD
Tizanidine—Asthenia—Cisplatin—lung cancer	0.000261	0.000327	CcSEcCtD
Tizanidine—Cardiac disorder—Methotrexate—lung cancer	0.000261	0.000327	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—lung cancer	0.00026	0.000326	CcSEcCtD
Tizanidine—Urticaria—Paclitaxel—lung cancer	0.00026	0.000325	CcSEcCtD
Tizanidine—Hypotension—Docetaxel—lung cancer	0.000259	0.000324	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—lung cancer	0.000259	0.000324	CcSEcCtD
Tizanidine—Abdominal pain—Paclitaxel—lung cancer	0.000259	0.000324	CcSEcCtD
Tizanidine—Body temperature increased—Paclitaxel—lung cancer	0.000259	0.000324	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—lung cancer	0.000257	0.000321	CcSEcCtD
Tizanidine—Angiopathy—Methotrexate—lung cancer	0.000255	0.00032	CcSEcCtD
Tizanidine—Vomiting—Irinotecan—lung cancer	0.000255	0.000319	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—lung cancer	0.000254	0.000319	CcSEcCtD
Tizanidine—Immune system disorder—Methotrexate—lung cancer	0.000254	0.000318	CcSEcCtD
Tizanidine—Mediastinal disorder—Methotrexate—lung cancer	0.000253	0.000317	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—lung cancer	0.000253	0.000317	CcSEcCtD
Tizanidine—Rash—Irinotecan—lung cancer	0.000253	0.000317	CcSEcCtD
Tizanidine—Dermatitis—Irinotecan—lung cancer	0.000253	0.000316	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000253	0.000316	CcSEcCtD
Tizanidine—Diarrhoea—Cisplatin—lung cancer	0.000249	0.000312	CcSEcCtD
Tizanidine—Paraesthesia—Docetaxel—lung cancer	0.000249	0.000312	CcSEcCtD
Tizanidine—Alopecia—Methotrexate—lung cancer	0.000248	0.000311	CcSEcCtD
Tizanidine—Vomiting—Gemcitabine—lung cancer	0.000248	0.000311	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—lung cancer	0.000248	0.00031	CcSEcCtD
Tizanidine—Dyspnoea—Docetaxel—lung cancer	0.000247	0.000309	CcSEcCtD
Tizanidine—Somnolence—Docetaxel—lung cancer	0.000246	0.000309	CcSEcCtD
Tizanidine—Mental disorder—Methotrexate—lung cancer	0.000246	0.000309	CcSEcCtD
Tizanidine—Rash—Gemcitabine—lung cancer	0.000246	0.000308	CcSEcCtD
Tizanidine—Dermatitis—Gemcitabine—lung cancer	0.000246	0.000308	CcSEcCtD
Tizanidine—Hypersensitivity—Etoposide—lung cancer	0.000246	0.000308	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—lung cancer	0.000245	0.000306	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—lung cancer	0.000244	0.000306	CcSEcCtD
Tizanidine—Dyspepsia—Docetaxel—lung cancer	0.000244	0.000306	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—lung cancer	0.000243	0.000305	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—lung cancer	0.000243	0.000305	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—lung cancer	0.000242	0.000303	CcSEcCtD
Tizanidine—Hypersensitivity—Paclitaxel—lung cancer	0.000241	0.000302	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—lung cancer	0.00024	0.000301	CcSEcCtD
Tizanidine—Asthenia—Etoposide—lung cancer	0.000239	0.0003	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—lung cancer	0.000239	0.0003	CcSEcCtD
Tizanidine—Fatigue—Docetaxel—lung cancer	0.000239	0.000299	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—lung cancer	0.000239	0.000299	CcSEcCtD
Tizanidine—Nausea—Irinotecan—lung cancer	0.000238	0.000298	CcSEcCtD
Tizanidine—Constipation—Docetaxel—lung cancer	0.000237	0.000297	CcSEcCtD
Tizanidine—Back pain—Methotrexate—lung cancer	0.000237	0.000297	CcSEcCtD
Tizanidine—Pruritus—Etoposide—lung cancer	0.000236	0.000296	CcSEcCtD
Tizanidine—Asthenia—Paclitaxel—lung cancer	0.000235	0.000294	CcSEcCtD
Tizanidine—Nausea—Gemcitabine—lung cancer	0.000232	0.000291	CcSEcCtD
Tizanidine—Vomiting—Cisplatin—lung cancer	0.000231	0.00029	CcSEcCtD
Tizanidine—Pruritus—Paclitaxel—lung cancer	0.000231	0.00029	CcSEcCtD
Tizanidine—Vision blurred—Methotrexate—lung cancer	0.000231	0.000289	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—lung cancer	0.00023	0.000288	CcSEcCtD
Tizanidine—Rash—Cisplatin—lung cancer	0.00023	0.000287	CcSEcCtD
Tizanidine—Dermatitis—Cisplatin—lung cancer	0.000229	0.000287	CcSEcCtD
Tizanidine—Feeling abnormal—Docetaxel—lung cancer	0.000228	0.000286	CcSEcCtD
Tizanidine—Diarrhoea—Etoposide—lung cancer	0.000228	0.000286	CcSEcCtD
Tizanidine—Ill-defined disorder—Methotrexate—lung cancer	0.000227	0.000284	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—lung cancer	0.000227	0.000284	CcSEcCtD
Tizanidine—Gastrointestinal pain—Docetaxel—lung cancer	0.000227	0.000284	CcSEcCtD
Tizanidine—Anaemia—Methotrexate—lung cancer	0.000226	0.000283	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—lung cancer	0.000226	0.000283	CcSEcCtD
Tizanidine—Diarrhoea—Paclitaxel—lung cancer	0.000224	0.00028	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—lung cancer	0.000221	0.000277	CcSEcCtD
Tizanidine—Malaise—Methotrexate—lung cancer	0.000221	0.000276	CcSEcCtD
Tizanidine—Dizziness—Etoposide—lung cancer	0.000221	0.000276	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—lung cancer	0.00022	0.000275	CcSEcCtD
Tizanidine—Vertigo—Methotrexate—lung cancer	0.00022	0.000275	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—lung cancer	0.000219	0.000275	CcSEcCtD
Tizanidine—Abdominal pain—Docetaxel—lung cancer	0.000219	0.000274	CcSEcCtD
Tizanidine—Body temperature increased—Docetaxel—lung cancer	0.000219	0.000274	CcSEcCtD
Tizanidine—Leukopenia—Methotrexate—lung cancer	0.000219	0.000274	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—lung cancer	0.000218	0.000272	CcSEcCtD
Tizanidine—Dizziness—Paclitaxel—lung cancer	0.000216	0.000271	CcSEcCtD
Tizanidine—Nausea—Cisplatin—lung cancer	0.000216	0.000271	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—lung cancer	0.000215	0.000269	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—lung cancer	0.000213	0.000267	CcSEcCtD
Tizanidine—Convulsion—Methotrexate—lung cancer	0.000212	0.000266	CcSEcCtD
Tizanidine—Vomiting—Etoposide—lung cancer	0.000212	0.000266	CcSEcCtD
Tizanidine—Rash—Etoposide—lung cancer	0.00021	0.000263	CcSEcCtD
Tizanidine—Dermatitis—Etoposide—lung cancer	0.00021	0.000263	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—lung cancer	0.000209	0.000262	CcSEcCtD
Tizanidine—Arthralgia—Methotrexate—lung cancer	0.000208	0.000261	CcSEcCtD
Tizanidine—Tension—Doxorubicin—lung cancer	0.000208	0.00026	CcSEcCtD
Tizanidine—Vomiting—Paclitaxel—lung cancer	0.000208	0.00026	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000207	0.000259	CcSEcCtD
Tizanidine—Rash—Paclitaxel—lung cancer	0.000206	0.000258	CcSEcCtD
Tizanidine—Dermatitis—Paclitaxel—lung cancer	0.000206	0.000258	CcSEcCtD
Tizanidine—Discomfort—Methotrexate—lung cancer	0.000206	0.000258	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—lung cancer	0.000206	0.000258	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—lung cancer	0.000205	0.000257	CcSEcCtD
Tizanidine—Hypersensitivity—Docetaxel—lung cancer	0.000204	0.000256	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—lung cancer	0.000204	0.000255	CcSEcCtD
Tizanidine—Confusional state—Methotrexate—lung cancer	0.000201	0.000252	CcSEcCtD
Tizanidine—Anaphylactic shock—Methotrexate—lung cancer	0.0002	0.00025	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—lung cancer	0.0002	0.00025	CcSEcCtD
Tizanidine—Asthenia—Docetaxel—lung cancer	0.000199	0.000249	CcSEcCtD
Tizanidine—Infection—Methotrexate—lung cancer	0.000198	0.000249	CcSEcCtD
Tizanidine—Nausea—Etoposide—lung cancer	0.000198	0.000248	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—lung cancer	0.000197	0.000246	CcSEcCtD
Tizanidine—Pruritus—Docetaxel—lung cancer	0.000196	0.000246	CcSEcCtD
Tizanidine—Nervous system disorder—Methotrexate—lung cancer	0.000196	0.000245	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—lung cancer	0.000196	0.000245	CcSEcCtD
Tizanidine—Thrombocytopenia—Methotrexate—lung cancer	0.000196	0.000245	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—lung cancer	0.000195	0.000244	CcSEcCtD
Tizanidine—Nausea—Paclitaxel—lung cancer	0.000194	0.000243	CcSEcCtD
Tizanidine—Skin disorder—Methotrexate—lung cancer	0.000194	0.000243	CcSEcCtD
Tizanidine—Hyperhidrosis—Methotrexate—lung cancer	0.000193	0.000242	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—lung cancer	0.000191	0.000239	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—lung cancer	0.00019	0.000239	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—lung cancer	0.00019	0.000238	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—lung cancer	0.00019	0.000238	CcSEcCtD
Tizanidine—Diarrhoea—Docetaxel—lung cancer	0.00019	0.000238	CcSEcCtD
Tizanidine—Hypotension—Methotrexate—lung cancer	0.000187	0.000234	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—lung cancer	0.000186	0.000233	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—lung cancer	0.000184	0.00023	CcSEcCtD
Tizanidine—Dizziness—Docetaxel—lung cancer	0.000183	0.00023	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—lung cancer	0.000183	0.000229	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000182	0.000228	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—lung cancer	0.00018	0.000226	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—lung cancer	0.00018	0.000225	CcSEcCtD
Tizanidine—Paraesthesia—Methotrexate—lung cancer	0.000179	0.000225	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000179	0.000224	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—lung cancer	0.000178	0.000223	CcSEcCtD
Tizanidine—Dyspnoea—Methotrexate—lung cancer	0.000178	0.000223	CcSEcCtD
Tizanidine—Somnolence—Methotrexate—lung cancer	0.000178	0.000222	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—lung cancer	0.000176	0.000221	CcSEcCtD
Tizanidine—Vomiting—Docetaxel—lung cancer	0.000176	0.000221	CcSEcCtD
Tizanidine—Dyspepsia—Methotrexate—lung cancer	0.000176	0.00022	CcSEcCtD
Tizanidine—Rash—Docetaxel—lung cancer	0.000175	0.000219	CcSEcCtD
Tizanidine—Dermatitis—Docetaxel—lung cancer	0.000175	0.000219	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—lung cancer	0.000174	0.000218	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—lung cancer	0.000173	0.000217	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—lung cancer	0.000173	0.000217	CcSEcCtD
Tizanidine—Fatigue—Methotrexate—lung cancer	0.000172	0.000216	CcSEcCtD
Tizanidine—Infection—Doxorubicin—lung cancer	0.000172	0.000215	CcSEcCtD
Tizanidine—Shock—Doxorubicin—lung cancer	0.00017	0.000213	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—lung cancer	0.00017	0.000212	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—lung cancer	0.000169	0.000212	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—lung cancer	0.000169	0.000211	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—lung cancer	0.000168	0.00021	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—lung cancer	0.000167	0.000209	CcSEcCtD
Tizanidine—Nausea—Docetaxel—lung cancer	0.000165	0.000206	CcSEcCtD
Tizanidine—Feeling abnormal—Methotrexate—lung cancer	0.000165	0.000206	CcSEcCtD
Tizanidine—Gastrointestinal pain—Methotrexate—lung cancer	0.000163	0.000205	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—lung cancer	0.000162	0.000202	CcSEcCtD
Tizanidine—Urticaria—Methotrexate—lung cancer	0.000159	0.000199	CcSEcCtD
Tizanidine—Body temperature increased—Methotrexate—lung cancer	0.000158	0.000198	CcSEcCtD
Tizanidine—Abdominal pain—Methotrexate—lung cancer	0.000158	0.000198	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000158	0.000197	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—lung cancer	0.000155	0.000195	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—lung cancer	0.000154	0.000193	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—lung cancer	0.000154	0.000193	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—lung cancer	0.000152	0.000191	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—lung cancer	0.000149	0.000187	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—lung cancer	0.000148	0.000185	CcSEcCtD
Tizanidine—Hypersensitivity—Methotrexate—lung cancer	0.000147	0.000184	CcSEcCtD
Tizanidine—Asthenia—Methotrexate—lung cancer	0.000143	0.00018	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—lung cancer	0.000143	0.000179	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000141	0.000177	CcSEcCtD
Tizanidine—Pruritus—Methotrexate—lung cancer	0.000141	0.000177	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—lung cancer	0.000137	0.000172	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—lung cancer	0.000137	0.000171	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—lung cancer	0.000137	0.000171	CcSEcCtD
Tizanidine—Diarrhoea—Methotrexate—lung cancer	0.000137	0.000171	CcSEcCtD
Tizanidine—Dizziness—Methotrexate—lung cancer	0.000132	0.000165	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—lung cancer	0.000127	0.00016	CcSEcCtD
Tizanidine—Vomiting—Methotrexate—lung cancer	0.000127	0.000159	CcSEcCtD
Tizanidine—Rash—Methotrexate—lung cancer	0.000126	0.000158	CcSEcCtD
Tizanidine—Dermatitis—Methotrexate—lung cancer	0.000126	0.000158	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—lung cancer	0.000124	0.000155	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—lung cancer	0.000122	0.000153	CcSEcCtD
Tizanidine—Nausea—Methotrexate—lung cancer	0.000119	0.000149	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—lung cancer	0.000118	0.000148	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—lung cancer	0.000114	0.000143	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—lung cancer	0.00011	0.000138	CcSEcCtD
Tizanidine—Rash—Doxorubicin—lung cancer	0.000109	0.000137	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—lung cancer	0.000109	0.000136	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—lung cancer	0.000103	0.000129	CcSEcCtD
Tizanidine—ADRA2B—Signaling by GPCR—IL2—lung cancer	3.47e-05	0.00022	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—HRAS—lung cancer	3.47e-05	0.00022	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TERT—lung cancer	3.46e-05	0.00022	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDOA—lung cancer	3.43e-05	0.000218	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—CXCL8—lung cancer	3.39e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FOXO3—lung cancer	3.38e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP1A1—lung cancer	3.37e-05	0.000214	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB3—lung cancer	3.37e-05	0.000214	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGFR1—lung cancer	3.36e-05	0.000213	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ERCC2—lung cancer	3.35e-05	0.000213	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NCOA3—lung cancer	3.33e-05	0.000212	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—KRAS—lung cancer	3.31e-05	0.000211	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAP2K1—lung cancer	3.31e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HIF1A—lung cancer	3.31e-05	0.00021	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CD—lung cancer	3.29e-05	0.000209	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—lung cancer	3.28e-05	0.000208	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.28e-05	0.000208	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—lung cancer	3.25e-05	0.000207	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ADCY1—lung cancer	3.24e-05	0.000206	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCG2—lung cancer	3.24e-05	0.000206	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL2—lung cancer	3.24e-05	0.000206	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TERT—lung cancer	3.23e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APOA1—lung cancer	3.19e-05	0.000203	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HPGDS—lung cancer	3.18e-05	0.000202	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ENO2—lung cancer	3.18e-05	0.000202	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AVP—lung cancer	3.16e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—lung cancer	3.16e-05	0.000201	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPP2R1B—lung cancer	3.16e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CB—lung cancer	3.16e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGFR1—lung cancer	3.14e-05	0.000199	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	3.12e-05	0.000198	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—lung cancer	3.1e-05	0.000197	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HIF1A—lung cancer	3.09e-05	0.000196	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTT1—lung cancer	3.08e-05	0.000196	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—lung cancer	3.06e-05	0.000195	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2A6—lung cancer	3.05e-05	0.000194	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GCLC—lung cancer	3.05e-05	0.000194	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1R—lung cancer	3.05e-05	0.000194	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—lung cancer	3.04e-05	0.000193	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	3.04e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—CXCL8—lung cancer	3.03e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CREBBP—lung cancer	3.02e-05	0.000192	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HES1—lung cancer	2.99e-05	0.00019	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APOA1—lung cancer	2.98e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—lung cancer	2.95e-05	0.000188	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—lung cancer	2.95e-05	0.000187	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RAF1—lung cancer	2.94e-05	0.000187	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—lung cancer	2.91e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APC—lung cancer	2.91e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KIT—lung cancer	2.91e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—NRAS—lung cancer	2.91e-05	0.000185	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—IL2—lung cancer	2.9e-05	0.000184	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—APOA1—lung cancer	2.89e-05	0.000184	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ENO1—lung cancer	2.89e-05	0.000184	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.88e-05	0.000183	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGF—lung cancer	2.88e-05	0.000183	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CB—lung cancer	2.87e-05	0.000182	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CD—lung cancer	2.86e-05	0.000182	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.84e-05	0.000181	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—lung cancer	2.82e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—HRAS—lung cancer	2.82e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—MAPK3—lung cancer	2.79e-05	0.000177	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—lung cancer	2.77e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—CXCL8—lung cancer	2.75e-05	0.000175	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BRAF—lung cancer	2.74e-05	0.000174	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB3—lung cancer	2.74e-05	0.000174	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APC—lung cancer	2.72e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—lung cancer	2.72e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KIT—lung cancer	2.72e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—NRAS—lung cancer	2.72e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6R—lung cancer	2.7e-05	0.000172	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CREBBP—lung cancer	2.7e-05	0.000172	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGF—lung cancer	2.69e-05	0.000171	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—EGFR—lung cancer	2.65e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—lung cancer	2.64e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL2—lung cancer	2.63e-05	0.000167	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TERT—lung cancer	2.62e-05	0.000167	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—MAPK3—lung cancer	2.61e-05	0.000166	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2E1—lung cancer	2.59e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—lung cancer	2.59e-05	0.000165	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAP2K1—lung cancer	2.58e-05	0.000164	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NQO1—lung cancer	2.56e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CD—lung cancer	2.56e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BRAF—lung cancer	2.56e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGFR1—lung cancer	2.55e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—lung cancer	2.54e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6R—lung cancer	2.53e-05	0.000161	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CREBBP—lung cancer	2.52e-05	0.00016	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—lung cancer	2.52e-05	0.00016	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.51e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HIF1A—lung cancer	2.51e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—KRAS—lung cancer	2.51e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CB—lung cancer	2.49e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—lung cancer	2.49e-05	0.000158	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.49e-05	0.000158	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—EGFR—lung cancer	2.48e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTGS2—lung cancer	2.47e-05	0.000157	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CREBBP—lung cancer	2.45e-05	0.000156	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APOA1—lung cancer	2.42e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAP2K1—lung cancer	2.41e-05	0.000153	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—lung cancer	2.4e-05	0.000152	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CD—lung cancer	2.39e-05	0.000152	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—lung cancer	2.37e-05	0.000151	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—KRAS—lung cancer	2.34e-05	0.000149	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CD—lung cancer	2.32e-05	0.000148	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—STK11—lung cancer	2.31e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—lung cancer	2.3e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MDM2—lung cancer	2.29e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—lung cancer	2.29e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAF1—lung cancer	2.29e-05	0.000145	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ERBB2—lung cancer	2.26e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CB—lung cancer	2.23e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MTOR—lung cancer	2.23e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—lung cancer	2.21e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APC—lung cancer	2.21e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KIT—lung cancer	2.21e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—NRAS—lung cancer	2.21e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGF—lung cancer	2.18e-05	0.000139	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.17e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PTEN—lung cancer	2.15e-05	0.000137	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—lung cancer	2.15e-05	0.000137	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CXCL8—lung cancer	2.14e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MDM2—lung cancer	2.14e-05	0.000136	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTP1—lung cancer	2.14e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAF1—lung cancer	2.13e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HRAS—lung cancer	2.13e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—MAPK3—lung cancer	2.12e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ERBB2—lung cancer	2.11e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—lung cancer	2.1e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MTOR—lung cancer	2.08e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CB—lung cancer	2.08e-05	0.000132	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CAT—lung cancer	2.08e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BRAF—lung cancer	2.08e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—lung cancer	2.07e-05	0.000132	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.07e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—EP300—lung cancer	2.05e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—lung cancer	2.05e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6R—lung cancer	2.05e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL2—lung cancer	2.05e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CREBBP—lung cancer	2.05e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—lung cancer	2.04e-05	0.00013	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CB—lung cancer	2.02e-05	0.000129	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ABCB1—lung cancer	2.02e-05	0.000129	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—EGFR—lung cancer	2.01e-05	0.000128	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTGS2—lung cancer	2.01e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CXCL8—lung cancer	2e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—lung cancer	2e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—JUN—lung cancer	1.99e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HRAS—lung cancer	1.99e-05	0.000126	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TYMS—lung cancer	1.99e-05	0.000126	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—lung cancer	1.96e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAP2K1—lung cancer	1.96e-05	0.000124	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CD—lung cancer	1.94e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—lung cancer	1.94e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—lung cancer	1.94e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1A—lung cancer	1.93e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PTEN—lung cancer	1.93e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—lung cancer	1.92e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—lung cancer	1.92e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL2—lung cancer	1.91e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—lung cancer	1.9e-05	0.000121	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—KRAS—lung cancer	1.9e-05	0.000121	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—lung cancer	1.88e-05	0.00012	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—lung cancer	1.87e-05	0.000119	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP1A1—lung cancer	1.86e-05	0.000118	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JUN—lung cancer	1.86e-05	0.000118	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ERCC2—lung cancer	1.85e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EP300—lung cancer	1.84e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—lung cancer	1.81e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1A—lung cancer	1.81e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PTEN—lung cancer	1.8e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SRC—lung cancer	1.79e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—lung cancer	1.76e-05	0.000112	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PTEN—lung cancer	1.75e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—lung cancer	1.75e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—lung cancer	1.74e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MDM2—lung cancer	1.74e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAF1—lung cancer	1.73e-05	0.00011	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—lung cancer	1.72e-05	0.00011	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NRAS—lung cancer	1.72e-05	0.000109	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EP300—lung cancer	1.72e-05	0.000109	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ERBB2—lung cancer	1.72e-05	0.000109	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MTOR—lung cancer	1.69e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CB—lung cancer	1.69e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SRC—lung cancer	1.67e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—EP300—lung cancer	1.67e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK3—lung cancer	1.65e-05	0.000105	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CXCL8—lung cancer	1.63e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—lung cancer	1.63e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HRAS—lung cancer	1.62e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—lung cancer	1.61e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NRAS—lung cancer	1.61e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—lung cancer	1.6e-05	0.000102	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—APOA1—lung cancer	1.6e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—lung cancer	1.57e-05	9.99e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—EGFR—lung cancer	1.57e-05	9.96e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—lung cancer	1.56e-05	9.9e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL2—lung cancer	1.55e-05	9.88e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—lung cancer	1.55e-05	9.83e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK3—lung cancer	1.54e-05	9.78e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.53e-05	9.72e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—lung cancer	1.52e-05	9.66e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—lung cancer	1.52e-05	9.63e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JUN—lung cancer	1.51e-05	9.61e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—lung cancer	1.5e-05	9.51e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KRAS—lung cancer	1.48e-05	9.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—lung cancer	1.47e-05	9.35e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1A—lung cancer	1.47e-05	9.32e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—EGFR—lung cancer	1.46e-05	9.3e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTEN—lung cancer	1.46e-05	9.3e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—lung cancer	1.46e-05	9.27e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—lung cancer	1.43e-05	9.07e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EP300—lung cancer	1.4e-05	8.87e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—lung cancer	1.39e-05	8.82e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KRAS—lung cancer	1.38e-05	8.79e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—lung cancer	1.36e-05	8.64e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SRC—lung cancer	1.36e-05	8.62e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CREBBP—lung cancer	1.35e-05	8.59e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—lung cancer	1.32e-05	8.4e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—lung cancer	1.32e-05	8.36e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—lung cancer	1.31e-05	8.31e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NRAS—lung cancer	1.31e-05	8.29e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CD—lung cancer	1.28e-05	8.15e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—lung cancer	1.27e-05	8.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—lung cancer	1.27e-05	8.04e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HRAS—lung cancer	1.26e-05	8e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK3—lung cancer	1.25e-05	7.94e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—lung cancer	1.24e-05	7.89e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—lung cancer	1.23e-05	7.84e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—lung cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—lung cancer	1.22e-05	7.73e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—lung cancer	1.2e-05	7.65e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—EGFR—lung cancer	1.19e-05	7.56e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HRAS—lung cancer	1.18e-05	7.47e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—lung cancer	1.13e-05	7.15e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KRAS—lung cancer	1.12e-05	7.14e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CB—lung cancer	1.12e-05	7.1e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—lung cancer	1.11e-05	7.06e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTGS2—lung cancer	1.11e-05	7.04e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—lung cancer	1.04e-05	6.6e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—lung cancer	1.03e-05	6.56e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—lung cancer	1.01e-05	6.41e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—lung cancer	9.98e-06	6.34e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PTEN—lung cancer	9.66e-06	6.14e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HRAS—lung cancer	9.55e-06	6.07e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—EP300—lung cancer	9.21e-06	5.85e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—lung cancer	9.14e-06	5.81e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—lung cancer	8.43e-06	5.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—lung cancer	6.81e-06	4.33e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—lung cancer	5.57e-06	3.54e-05	CbGpPWpGaD
